axiom a
Recently Published Documents


TOTAL DOCUMENTS

190
(FIVE YEARS 16)

H-INDEX

27
(FIVE YEARS 1)

Author(s):  
Seyed Mohsen Moosavi ◽  
Khosro Tajbakhsh
Keyword(s):  

2021 ◽  
Author(s):  
Szilárd Gy. Révész

In this paper we work out a Riemann–von Mangoldt type formula for the summatory function := , where is an arithmetical semigroup (a Beurling generalized system of integers) and is the corresponding von Mangoldt function attaining with a prime element and zero otherwise. On the way towards this formula, we prove explicit estimates on the Beurling zeta function , belonging to , to the number of zeroes of in various regions, in particular within the critical strip where the analytic continuation exists, and to the magnitude of the logarithmic derivative of , under the sole additional assumption that Knopfmacher’s Axiom A is satisfied. We also construct a technically useful broken line contour to which the technic of integral transformation can be well applied. The whole work serves as a first step towards a further study of the distribution of zeros of the Beurling zeta function, providing appropriate zero density and zero clustering estimates, to be presented in the continuation of this paper.


Axioms ◽  
2021 ◽  
Vol 10 (1) ◽  
pp. 38
Author(s):  
Kazuhiro Sakai ◽  
Naoya Sumi

In this paper, it is proved that every diffeomorphism possessing the filtrated pseudo-orbit shadowing property admits an approximately shadowable Lebesgue measure. Furthermore, the C1-interior of the set of diffeomorphisms possessing the filtrated pseudo-orbit shadowing property is characterized as the set of diffeomorphisms satisfying both Axiom A and the no-cycle condition. As a corollary, it is proved that there exists a C1-open set of diffeomorphisms, any element of which does not have the shadowing property but admits an approximately shadowable Lebesgue measure.


2021 ◽  
Vol 15 (1) ◽  
pp. 51-60
Author(s):  
Minh Hien Huynh ◽  
◽  
Van Nam Vo ◽  
Tinh Le ◽  
Thi Dai Trang Nguyen

This paper deals with clustering of periodic orbits of the hyperbolic toral automorphism induced by matrix A. We prove that Ta satisfies the Axiom A. The clustering of periodic orbits of Ta is ivestigated via the notion of 'p-closeness' of periodic sequences of the respective symbolic dynamical system. We also provide the number of clusters of periodic sequences with given periods in the case of 2-closeness.


2021 ◽  
Vol 19 (1) ◽  
pp. 470-476
Author(s):  
Manseob Lee

Abstract In this paper, we will assume M M to be a compact smooth manifold and f : M → M f:M\to M to be a diffeomorphism. We herein demonstrate that a C 1 {C}^{1} generic diffeomorphism f f is Axiom A and has no cycles if f f is asymptotic measure expansive. Additionally, for a C 1 {C}^{1} generic diffeomorphism f f , if a homoclinic class H ( p , f ) H\left(\hspace{0.08em}p,f) that contains a hyperbolic periodic point p p of f f is asymptotic measure-expansive, then H ( p , f ) H\left(\hspace{0.08em}p,f) is hyperbolic of f f .


2020 ◽  
pp. 105-114
Author(s):  
Otto E. Rössler
Keyword(s):  

2020 ◽  
Vol 28 (2) ◽  
pp. 211-215
Author(s):  
Karol Pąk

Summary The foundation of the Mizar Mathematical Library [2], is first-order Tarski-Grothendieck set theory. However, the foundation explicitly refers only to Tarski’s Axiom A, which states that for every set X there is a Tarski universe U such that X ∈ U. In this article, we prove, using the Mizar [3] formalism, that the Grothendieck name is justified. We show the relationship between Tarski and Grothendieck universe. First we prove in Theorem (17) that every Grothendieck universe satisfies Tarski’s Axiom A. Then in Theorem (18) we prove that every Grothendieck universe that contains a given set X, even the least (with respect to inclusion) denoted by GrothendieckUniverseX, has as a subset the least (with respect to inclusion) Tarski universe that contains X, denoted by the Tarski-ClassX. Since Tarski universes, as opposed to Grothendieck universes [5], might not be transitive (called epsilon-transitive in the Mizar Mathematical Library [1]) we focused our attention to demonstrate that Tarski-Class X ⊊ GrothendieckUniverse X for some X. Then we show in Theorem (19) that Tarski-ClassX where X is the singleton of any infinite set is a proper subset of GrothendieckUniverseX. Finally we show that Tarski-Class X = GrothendieckUniverse X holds under the assumption that X is a transitive set. The formalisation is an extension of the formalisation used in [4].


2019 ◽  
Vol 60 (4) ◽  
pp. 587-616
Author(s):  
Heike Mildenberger ◽  
Saharon Shelah
Keyword(s):  
Axiom A ◽  

2019 ◽  
Vol 76 (1) ◽  
pp. 29-48 ◽  
Author(s):  
Wescley Bonomo ◽  
Paulo Varandas
Keyword(s):  

2019 ◽  
Vol 7 (18) ◽  
pp. 3053-3060
Author(s):  
Massimo Fioranelli ◽  
Alireza Sepehri ◽  
Maria Grazia Roccia ◽  
Cota Linda ◽  
Chiara Rossi ◽  
...  

Increasing incidence and poor outcome of chronic non-communicable diseases in western population would require a paradigm shift in the treatments. Guidelines-based medical approaches continue to be the standard rule in clinical practice, although only less than 15% of them are based on high-quality research. For each person who benefits from the 10 best-selling drugs in the USA, a number between 4 and 25 has no one beneficial effect. The reductionist linear medicine method does not offer solutions in the non-manifest preclinical stage of the disease when it would still be possible to reverse the pathological progression and the axiom "a drug, a target, a symptom" are still inconclusive. Needs additional tools to address these challenges. System Medicine considers the disease as a dysregulation of the biological networks that changes throughout the evolution of the pathological process and with the comorbidities development. The strength of the networks indicates their ability to withstand dysregulations during the perturbation phases, returning to the state of stability. The treatment of dysregulated networks before the symptomatological manifestation emerges offers the possibility of treating and preventing pathologies in the preclinical phase and potentially reversing the pathological process, stopping it or preventing comorbidities. Furthermore, treating shared networks instead of individual phenotypic symptoms can reduce drug use, offering a solution to the problem of ineffective drug use.


Sign in / Sign up

Export Citation Format

Share Document